Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences to Acquire TEI Biosciences and TEI Medical
Broadens Integra's position as a leader in regenerative wound care and tissue repair Adds new selling capabilities to the wound care clinic and enhances current sales channel in both burn centers and Operating Rooms (OR) Management to Host Conference Call Tomorrow PLAINSBORO, N.J.
View HTML
Toggle Summary Integra to Complete Tax-Free Spin-Off of SeaSpine on July 1, 2015
Declares Record Date of June 19, 2015 and Share Distribution Date of July 1, 2015
View HTML
Toggle Summary Richard Gorelick, Corporate Vice President and General Counsel of Integra LifeSciences, Named NJBIZ General Counsel of the Year Winner
PLAINSBORO, N.J., June 4, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Richard Gorelick, Corporate Vice President, General Counsel, Administration and Secretary, was named as 2015 NJBIZ General Counsel of the Year of public companies with
View HTML
Toggle Summary Integra LifeSciences and SeaSpine to Present at the Jefferies 2015 Global Healthcare Conference in June
PLAINSBORO, N.J., May 26, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will make the following presentations at the Jefferies 2015 Global Healthcare Conference in New York City: At 4:00PM ET on Tuesday, June 2, 2015, Mr.
View HTML
Toggle Summary Integra LifeSciences to Provide Historical Financials Adjusted for Discontinued Operations and Host Conference Call on May 26, 2015
PLAINSBORO, N.J., May 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to release historical financial information adjusted for the planned spin-off of its spine business, to become SeaSpine Holdings Corporation.
View HTML
Toggle Summary SeaSpine to Join Integra LifeSciences at the 2015 UBS Global Healthcare Conference
PLAINSBORO, N.J., May 13, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Keith Valentine, Chief Executive Officer of SeaSpine, will join Integra to present at the 2015 UBS Global Healthcare Conference.
View HTML
Toggle Summary Integra LifeSciences Features New MAYFIELD(R) 2 System at the American Association of Neurological Surgeons Annual Scientific Meeting
PLAINSBORO, N.J., May 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of the new MAYFIELD ® 2 system for rigid cranial fixation. The MAYFIELD 2 system will be featured at the Integra LifeSciences exhibition booth at the American
View HTML
Toggle Summary Integra LifeSciences Reports First Quarter 2015 Financial Results
Revenue Increased 8.7% to $233.7 Million Reported EPS Increased to $0.25; Adjusted EPS Increased to $0.76 Full Year 2015 Revenue and EPS Guidance Raised PLAINSBORO, N.J., April 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results
View HTML
Toggle Summary Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine
PLAINSBORO, N.J., April 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment, effective May 1, 2015, of Keith Valentine as Chief Executive Officer of SeaSpine Holdings Corporation, which will be an independent, publicly traded company
View HTML
Toggle Summary Integra LifeSciences to Participate in Three Investor Conferences in May
PLAINSBORO, N.J., April 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences in May: At 2:10PM ET on Wednesday, May 6, 2015, Glenn Coleman, Integra's Chief Financial Officer, will present at the
View HTML